Abstract:BACKGROUND:Loss-of-function mutations in interferon regulatory factor-6 (IRF6) are responsible for about 70% of cases of Van Der Woude Syndrome (VWS), an autosomal dominant developmental disorder characterized by pits and/or sinuses of the lower lip and cleft lip, cleft palate, or both.METHODS:We collected a Chinese Han VWS pedigree, performed sequencing and screening for the causal gene mutant. Initially, species conservation analysis and homology protein modeling were used to predict the potential pathogenicity of mutations. To test whether a VWS family-derived mutant variant of IRF6 retained function, we carried out rescue assays in irf6 maternal-null mutant zebrafish embryos. To assess protein stability, we overexpressed reference and family-variants of IRF6 in vitro.RESULTS:We focused on a VWS family that includes a son with bilateral lip pits, uvula fissa and his father with bilateral cleft lip and palate. After sequencing and screening, a frameshift mutation of IRF6 was identified as the potential causal variant (NM.006147.3, c.1088-1091delTCTA; p.Ile363ArgfsTer33). The residues in this position are strongly conserved among species and homology modeling suggests the variant alters the protein structure. In irf6 maternal-null mutant zebrafish embryos the periderm differentiates abnormally and the embryos rupture and die during gastrulation. Injection of mRNA encoding the reference variant of human IRF6, but not of the frame-shift variant, rescued such embryos through gastrulation. Upon overexpression in HEK293FT cells, the IRF6 frame-shift mutant was relatively unstable and was preferentially targeted to the proteasome in comparison to the reference variant.CONCLUSION:In this VWS pedigree, a novel frameshift of IRF6 was identified as the likely causative gene variant. It is a lost function mutation which could not rescue abnormal periderm phenotype in irf6 maternal-null zebrafish and which causes the protein be unstable through proteasome-dependent degradation.

[Clinical and Genetic Features of Chinese Kindreds with Van Der Woude Syndrome Caused by Interferon Regulatory Factor 6 Mutation].

Novel IRF6 mutations in Chinese patients with Van der Woude syndrome.

[Genetic Analysis of a Family of Van Der Woude Syndrome].

Identification of Novel Mutations of IRF6 Gene in Chinese Families with Van Der Woude Syndrome.

A clinical and multi‐omics study of Van der Woude syndrome in three generations of a Chinese family

[Identification of Three Novel Mutations of IRF6 in Chinese Families with Van Der Woude Syndrome].

Clinical and Genetic Features in Five Chinese Kindreds with Van der Woude Syndrome

Novel IRF6 Mutations in Chinese Han Families with Van Der Woude Syndrome.

Causal Variations at IRF6 Gene Identified in Van Der Woude Syndrome Pedigrees.

Screen for IRF6 Gene Mutation in a Van Der Woude Syndrome Family in Shanxi Province

A novel IRF6 gene mutation impacting the regulation of TGFβ2-AS1 in the TGFβ pathway: A mechanism in the development of Van der Woude syndrome

Functional Characterization of a Novel IRF6 Frameshift Mutation from a Van Der Woude Syndrome Family.

Genetic heterogeneity in Van der Woude syndrome: identification of NOL4 and IRF6 haplotype from the noncoding region as candidates in two families

The Novel Compound Heterozygous Mutations, V434del and W666X, in WFS1 Gene Causing the Wolfram Syndrome in a Chinese Family

Association between IRF6 V274I and non-syndromic cleft lip with or without cleft palate in west Chinese population

A comprehensive genotype-phenotype evaluation of eight Chinese probands with Waardenburg syndrome

Analysis of genotype–phenotype relationships in 90 Chinese probands with Waardenburg syndrome

[Clinical and Genetic Characteristics of Chinese Patients with Waardenburg Syndrome].

Molecular and Clinical Profile of VWD in a Large Cohort of Chinese Population: Application of Next Generation Sequencing and CNVplex® Technique

Novel Mutations of PAX3, MITF, and SOX10 Genes in Chinese Patients with Type I or Type II Waardenburg Syndrome.

Clinical and Genetic Investigation of Families with Waardenburg Syndrome Type 2